The U.S. Food and Drug Administration approved Soleno Therapeutics' drug to treat a rare genetic disorder on Wednesday, ...
“Anxiety disorders arise from a blend of genetic, environmental, and psychological factors. While we know that genetics plays a significant role, it’s not the sole determinant of whether ...
The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...
today shared research on the value of both genetic and functional testing in diagnosing mitochondrial disorders at the 2025 ACMG Annual Clinical Genetics Meeting, in Los Angeles, CA. The session ...